Jefferies Unveils High-Upside European Midcap Stocks for the Second Half

Navigating the European Midcap Landscape in H2

As global financial markets cross into the second half of the year, institutional investors are increasingly turning their attention away from overcrowded mega-cap tech plays and toward overlooked corners of the equity universe. According to a comprehensive research note from Jefferies, European midcap stocks are exhibiting strengthening fundamentals, underpinned by robust order books and superior earnings visibility following a better-than-expected second-quarter corporate reporting cycle.

For much of the preceding year, European midcaps labored under a cloud of macroeconomic uncertainty, sticky inflation pressures, tariff concerns, and fluctuating central bank rate trajectories. However, recent quarterly updates have dispelled some of that pessimism. Positive earnings surprises have translated directly into material consensus estimate upgrades, creating fertile ground for stock pickers seeking mispriced growth and quality cyclicals trading at attractive valuation discounts.

Standout Sectors and Preferred Corporate Picks

Jefferies’ revised strategy features targeted preferences across several key industrial and consumer segments, reflecting changing macroeconomic realities and structural growth drivers:

• Inficon and Industrial Recovery: Having successfully navigated prior tariff uncertainties and foreign-exchange pressures, Inficon remains a cornerstone top pick. Its operational turnaround underscores the robust recovery potential within specialized industrial technology.
• Systemair and Data-Centre Cooling: Systemair delivered an impressive fiscal first quarter, reporting a 13% year-on-year surge in adjusted EBIT that beat consensus estimates by 4%. The company is benefiting significantly from broad-based organic growth and escalating demand for data-centre cooling infrastructure fueled by artificial intelligence spending.
• Redcare Pharmacy and DACH Preferences: Within the DACH midcap universe, Redcare Pharmacy has emerged as a preferred name on the back of appealing valuation levels and supportive sentiment shifts.
• Volex and Global Expansion: Volex continues to command a strong Buy rating after delivering performance metrics well ahead of initial projections, prompting management to raise full-year guidance early in the financial calendar alongside upward revisions through fiscal 2029.
• Acerinox: Benefiting from a revised price target of €22, Acerinox captures attention due to its favorable U.S.-focused earnings mix, active capacity expansions, and stabilizing operational backdrops across European domestic markets.

Macroeconomic Context and Market Implications

The broader market significance of Jefferies' midcap thesis lies in the historic valuation spread currently separating midcaps from their large-cap peers. While mega-cap equities have absorbed the lion's share of passive and active institutional inflows, European midcaps have remained relatively under-owned.

As European central banks navigate their monetary easing cycles and domestic fiscal measures begin to filter through the real economy, export-oriented midcaps and industrial automation players are uniquely positioned to leverage a rebound in demand. Companies exposed to structural themes—such as warehouse automation, advanced electrification, and digital infrastructure—offer robust cash flow generation that is often decoupled from sluggish local economic growth.

Strategic Guidance for Investors

For institutional investors and sophisticated private wealth managers, the current market juncture presents a tactical window to accumulate high-quality European mid-tier enterprises. Key metrics to monitor heading through the remainder of the year include:

• Order intake sustainability and book-to-bill ratios across industrial automation and HVAC suppliers.
• Margin defense resilience in the face of fluctuating currency valuations and input cost pressures.
• Management commentary regarding the durability of forward-looking financial targets amid evolving geopolitical trade dynamics.

Ultimately, while macro volatility cannot be entirely discounted, the fundamental re-rating currently underway in select European midcaps suggests that disciplined, bottom-up stock selection will reward investors who look beyond headline indices.